share_log

Earnings Call Summary | Marpai(MRAI.US) Q4 2023 Earnings Conference

Earnings Call Summary | Marpai(MRAI.US) Q4 2023 Earnings Conference

業績電話會議摘要 | Marpai (MRAI.US) 2023 年第四季度業績會議
富途資訊 ·  03/27 21:37  · 電話會議

The following is a summary of the Marpai, Inc. (MRAI) Q4 2023 Earnings Call Transcript:

以下是Marpai, Inc.(MRAI)2023年第四季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Marpai reported Q4 net revenues of $8.7 million, a 12% improvement over the same quarter in 2022.

  • Gross profit was $3 million, a 6.5% improvement over Q4 2022.

  • The company reported a net loss of $5 million, a 41.1% improvement from Q4 2022. For the full year, net revenues were $37.2 million, a 52.6% increase year-over-year.

  • Marpai公佈的第四季度淨收入爲870萬美元,比2022年同期增長12%。

  • 毛利爲300萬美元,比2022年第四季度增長6.5%。

  • 該公司報告淨虧損500萬美元,比2022年第四季度增長41.1%。全年淨收入爲3,720萬美元,同比增長52.6%。

Business Progress:

業務進展:

  • Marpai is expecting significant growth by shifting employers to self-funded plans and introducing specialties in clinical programs to manage chronic conditions.

  • The company is revamping their customer service department and is focusing on operational excellence, including the integration of Maestro Health. Additionally, Marpai is leveraging artificial intelligence for task automation to improve service quality and speed.

  • Marpai預計,通過將僱主轉向自籌資金的計劃,並在臨床項目中引入專業來管理慢性病,將實現顯著增長。

  • 該公司正在改造其客戶服務部門,專注於卓越運營,包括整合Maestro Health。此外,Marpai正在利用人工智能實現任務自動化,以提高服務質量和速度。

More details: Marpai IR

更多詳情: Marpai IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論